Latest Organofluorides Stories
Bernstein Liebhard LLP is representing numerous plaintiffs who have filed Risperdal lawsuits in the Pennsylvania litigation, all of whom allegedly developed gynecomastia (male breast growth) due
DUBLIN, April 1, 2015 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/bv73wq/fluoropolymer) has announced the addition of the"Fluoropolymer
Results served as basis for regulatory filing with U.S.
DALLAS, March 27, 2015 /PRNewswire/ -- The Fluoropolymers Market is expected to grow at a CAGR of 5.2%, in terms of volume, over the next five years to reach 380.2 KT by
Conference Call Scheduled for Today at 4:30 p.m. ET to Provide Investor Update SAN DIEGO, March 24, 2015 /PRNewswire/ -- Lpath, Inc.
DALLAS, March 24, 2015 /PRNewswire/ -- The report "Fluoropolymer Market by Type (PTFE, PVDF, FEP, and Fluoroelastomers), by Application (Automotive & Transportation,
TOKYO and SAN FRANCISCO, March 24, 2015 /PRNewswire/ -- Astellas Pharma Inc. (Tokyo: 4503) and Medivation, Inc.
Bernstein Liebhard LLP is representing numerous Risperdal plaintiffs in the Pennsylvania litigation, all of whom allegedly experienced excessive male breast growth due to their use of the antipsychotic
PHILADELPHIA, March 20, 2015 /PRNewswire/ -- A Philadelphia jury today affirmed by a 10-2 vote that Janssen Pharmaceuticals, a division of Johnson & Johnson, failed to warn of the risk to
WASHINGTON, March 18, 2015 /PRNewswire/ -- USPLabs Inc. has been made aware that U.S.
- Stoppage; cessation (of labor).
- A standing still or idling (of mills, factories, etc.).